Skip to main content

1-50 of 5,068 results for subject:Diabetes

Type

-
Early day motions (63)
+ Legislation (11) + Bills (6) + Public bills (6) + Private members' bills (6)
-
Presentation bills (2)
-
Ten minute rule bills (4)
+ Delegated legislation (5)
-
Statutory instruments (5)
+ Members' contributions (1,960)
-
Business questions (25)
-
Maiden speeches (1)
-
Oral answers to questions (281)
-
Oral question time interventions (4)
+ Oral questions (294)
-
Prime Minister's questions (25)
-
Topical questions (13)
-
Points of order (1)
-
Proceeding contributions (1,381)
+ Parliamentary committees (26) + Committee proceedings (9)
-
Committee of the Whole House (HL) (1)
-
Grand Committee proceedings (HC) (1)
-
Public Bill Committee proceedings (2)
-
Select Committee oral evidence (5)
-
Select Committee reports (5)
-
Select Committee reports (Government responses) (4)
-
Select Committee written evidence (10)
+ Parliamentary papers (105)
-
Annual reports (1)
-
Command papers (3)
-
Consultation papers (2)
-
Deposited papers (81)
-
House of Commons papers (18)
-
Impact assessments (3)
-
Unprinted papers (3)
+ Parliamentary proceedings (101) + Debates (71)
-
Adjournment debates (28)
-
Backbench debates (4)
+ Committee proceedings (9)
-
Committee of the Whole House (HL) (1)
-
Grand Committee proceedings (HC) (1)
-
Public Bill Committee proceedings (2)
-
Select Committee oral evidence (5)
-
e-petition debates (1)
+ Legislative debates (9)
-
Debates on bills (8)
-
Debates on delegated legislation (1)
-
Opposition days (1)
-
Questions for short debate (11)
+ Petitions and observations (7)
-
Observations on petitions (3)
-
Paper petitions (4)
+ Statements (16) + Oral statements (1)
-
Ministerial statements (1)
-
Written statements (15)
+ Written corrections (7)
-
Ministerial corrections (7)
+ Parliamentary questions (3,130)
-
Business questions (25)
+ Oral questions (294)
-
Prime Minister's questions (25)
-
Topical questions (13)
-
Written questions (2,811)
+ Petitions and observations (7)
-
Observations on petitions (3)
-
Paper petitions (4)
+ Research briefings (18)
-
Commons Briefing papers (4)
-
Commons Debate packs (5)
+ Lords In Focus (3)
-
Lords In Focus - Topical (3)
+ Lords Library Briefings (2)
-
Lords Library Briefings - Topical (1)
-
POSTbriefs (1)
-
POSTnotes (3)

House

Session

Year

Department

More

Member

More

Primary member

More

Answering member

More

Legislative stage

Legislation

More

Subject

More

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

To ask the Secretary of State for Health and Social Care, whether she has assessed the potential impact of funding preventative interventions for people with pre-diabetes and early Type 2 diabetes on the economy.

Asked by
Roz Savage (Liberal Democrat)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
15 September 2026
Reference
25324
House
House of Commons

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of earlier diagnosis and preventative technologies, including continuous glucose monitoring, on reducing the economic impact of Type 2 diabetes.

Asked by
Roz Savage (Liberal Democrat)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
15 September 2026
Reference
25323
House
House of Commons

To ask the Secretary of State for Health and Social Care, what plans the department has to improve public awareness of peripheral neuropathy and early signs of diabetes-related foot complications.

Asked by
Lee Dillon (Liberal Democrat)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Tabled
Date
11 September 2026
Reference
29302
House
House of Commons

To ask the Secretary of State for Health and Social Care, what steps the department is taking to reduce the incidence of diabetes-related lower-limb amputations, including by improving early detection of peripheral neuropathy and access to preventative foot-care services.

Asked by
Lee Dillon (Liberal Democrat)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Tabled
Date
11 September 2026
Reference
29300
House
House of Commons

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help ensure that all Integrated Care Boards have access to multidisciplinary specialist foot-care teams for people with diabetes.

Asked by
Lee Dillon (Liberal Democrat)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Tabled
Date
11 September 2026
Reference
29301
House
House of Commons

Motion that this House has considered the potential merits of reform of the vascular sector. Agreed to question.

Lead member
Jim Shannon
Answering member
James Frith
Department
Department of Health and Social Care
Type
Backbench debates
Date
10 September 2026
Reference
790 cc413-431WH
House
House of Commons

I beg to move,

That this House has considered the potential merits of reform of the vascular sector.

It is a real pleasure to serve under your chairship, Dr Huq. Last night, you were in the Adjournment debate, and today you are chairing a Westminster Hall debate. Your talents are incredible—well done...

Member
Jim Shannon (Democratic Unionist Party)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 cc413-4WH
House
House of Commons

The statistics that the hon. Gentleman highlights should shock us all. If those were the statistics for dealing with any cancer, we would simply find them unacceptable. Does he agree that vascular disease, because it is not treated in the same way as cancer, in some cases ends up being...

Member
Zubir Ahmed (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 c414WH
House
House of Commons

I thank the hon. Gentleman for that intervention. He has rightly said that, when it comes to vascular disease, while it is equal with cancer in its severity and in the numbers who lose their lives, it is not treated the same. Today’s debate perhaps gives us a chance to...

Member
Jim Shannon (Democratic Unionist Party)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 cc414-7WH
House
House of Commons

It is a pleasure to serve under your chairmanship today, Dr Huq. I thank the hon. Member for Strangford (Jim Shannon) for securing this debate.

The publication of the 2026 cardiovascular disease modern service framework is a welcome step towards realising our commitment to a more preventative, community-focused health service. It...

Member
Juliet Campbell (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 cc417-9WH
House
House of Commons

It is a pleasure to serve under your chairship, Dr Huq. I welcome the Minister, my hon. Friend the Member for Bury North (Mr Frith), to his place—he knows that I was in his place not too long ago, and I will be kind to him in my asks. I...

Member
Zubir Ahmed (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 cc419-421WH
House
House of Commons

It is a pleasure to serve under your chairship, Dr Huq. I welcome the Minister and the shadow Minister, the hon. Member for Solihull West and Shirley (Dr Shastri-Hurst), to their places. Most of all, I thank the hon. Member for Strangford (Jim Shannon) for securing this important debate. He...

Member
Helen Morgan (Liberal Democrat)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 cc421-2WH
House
House of Commons

It is a pleasure to serve under your chairmanship this afternoon, Dr Huq. As the hon. Member for Glasgow South West (Dr Ahmed)—I call him my hon. Friend—pointed out, I have a particular interest in this subject. It is a number of years since I held a licence to practise,...

Member
Neil Shastri-Hurst (Conservative)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 cc422-5WH
House
House of Commons

It is a genuine pleasure to serve under your chairship, Dr Huq, and to join you again in Parliament. We worked together before and it is an honour to be here today.

As is customary, I would like to thank the hon. Member for Strangford (Jim Shannon) for securing this important...

Member
James Frith (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 c425WH
House
House of Commons

The Minister is making a powerful case that to govern is to make decisions. Does he agree that when it comes to the NHS, while we talk a lot about money, input and investment, today we are ultimately talking about reform, taking different decisions and showing leadership? Does he agree...

Member
Zubir Ahmed (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 c426WH
House
House of Commons

I concur fully with my hon. Friend’s point. I noted his earlier remark about the commissioning of outcomes, and I think that one of the developing themes adjoining my own thinking and my brief is the need to get better at commissioning outcomes, considering whole populations, communities and places, and...

Member
James Frith (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 c426WH
House
House of Commons

I thank the Minister very much for that response; it is incredibly helpful. There seems to be a postcode lottery, where those who need care get it in some places but not in others. Does the Minister feel that his policy will ensure deliverability across all postcodes, not just in...

Member
Jim Shannon (Democratic Unionist Party)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 c426WH
House
House of Commons

That is a very fair and right challenge. This is not about endorsing patchwork provision; it is about understanding that, whether because of the physiological, social, environmental or behavioural differences that exist, care is not evenly distributed. We should have standards that we expect nationally, but we should also commission...

Member
James Frith (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 c426WH
House
House of Commons

I agree with the Minister that services should be locally commissioned, particularly where there is a high prevalence of a certain type of disease or condition, because it allows for the shaping of those services to local circumstances. There is evidence, is there not, that local commissioning has not given...

Member
Helen Morgan (Liberal Democrat)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 c426WH
House
House of Commons

I hope that my further remarks will address that very point; I am happy to pick it up with the hon. Member in due course if they do not satisfy.

ICBs will use national modern service frameworks set by the Government and guidance to create the right services for their areas....

Member
James Frith (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 cc426-7WH
House
House of Commons

I thank the Minister for his generosity in giving us a chance to ask questions. One of the areas that the APPG and we elected representatives have identified is that there are areas of deprivation where levels of vascular ill health and amputations are higher. What can be done to...

Member
Jim Shannon (Democratic Unionist Party)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 c427WH
House
House of Commons

The hon. Member is absolutely right. We have to keep ICBs and their commissioning powers accountable to local jurisdictions. I will say a bit more on that in due course, but we are on the same page.

To facilitate faster assessments we also need to speed up and make earlier diagnoses,...

Member
James Frith (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 cc427-9WH
House
House of Commons

I will be quick, because I know the Minister wants to wind up and I am sure he has plenty of things to do. He is talking powerfully about the digital offering that the Labour Government are providing to patients today in England and, more importantly, our ambitions for the...

Member
Zubir Ahmed (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 c429WH
House
House of Commons

In the humblest of terms, I would be very happy to visit and speak to my Scottish counterparts to ensure that they take that opportunity, and that any development, whether on compatibility, operability, the learnings from the NHS app in how we then develop NHS Online—that sounds a bit too...

Member
James Frith (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 c429WH
House
House of Commons

The hon. Member for Glasgow South West (Dr Ahmed) has nabbed my request—it is not about green cheese, by the way, Minister. My request is that the kindness the Minister has extended in respect of the hon. Gentleman and the Scottish health service is also extended to us in Northern...

Member
Jim Shannon (Democratic Unionist Party)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 c429WH
House
House of Commons

I will take any excuse I can to come to Northern Ireland, and I hope my private office has noted that.

In closing, our approach to improving the treatment of vascular diseases is closely aligned with the reforms in the APPG report and the APPG’s ambitions. I know that, of course,...

Member
James Frith (Labour)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 cc429-430WH
House
House of Commons

I thank everyone for their contributions, including the hon. Member for Broxtowe (Juliet Campbell). It is perhaps disquieting to understand that the hon. Lady has four times the number of people with vascular health issues in her constituency compared with elsewhere. That indicates a level of deprivation that is seen...

Member
Jim Shannon (Democratic Unionist Party)
Type
Proceeding contributions
Date
10 September 2026
Reference
790 cc430-1WH
House
House of Commons

To ask the Secretary of State for Health and Social Care, with reference to her Department's press release entitled New heart disease and strokes plan to save thousands of lives, published on 7 July 2026, whether she plans to make continuous glucose monitoring available to participants in the NHS Diabetes...

Asked by
Roz Savage (Liberal Democrat)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
7 September 2026
Reference
25317
House
House of Commons

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential merits of extending eligibility for continuous glucose monitoring to people with pre-diabetes and those with early Type 2 diabetes.

Asked by
Roz Savage (Liberal Democrat)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
7 September 2026
Reference
25318
House
House of Commons

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the evidence on the effectiveness of continuous glucose monitoring in supporting behaviour change and reducing progression from pre-diabetes to Type 2 diabetes.

Asked by
Roz Savage (Liberal Democrat)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
7 September 2026
Reference
25319
House
House of Commons

To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of wider access to continuous glucose monitoring on the level of health inequalities associated with Type 2 diabetes.

Asked by
Roz Savage (Liberal Democrat)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
7 September 2026
Reference
25321
House
House of Commons

I thank my hon. Friend for that contribution. Having worked in neonatal care services and areas of specialised services in the NHS for 10 years, I understand that one of the benefits of NHS England was that it brought together highly specialised services, ensured consistent service specifications and uplifted the...

Member
Danny Beales (Labour)
Type
Proceeding contributions
Date
7 September 2026
Reference
790 c797
House
House of Commons

A Westminster Hall debate has been scheduled for 10 September 2026 on the potential merits of reform of the vascular sector.

Type
Commons Briefing papers
Date
3 September 2026
Reference
CBP-11081
Type
House of Commons papers; Select Committee written evidence; Parliamentary committees
Committee
Health and Social Care Committee
Date
2 September 2026
Reference
HC 238 2026-27
House
House of Commons

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to support research into the prevention, treatment and management of type 1 diabetes.

Asked by
Oliver Dowden (Conservative)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Tabled
Date
28 August 2026
Reference
21187
House
House of Commons

To ask the Secretary of State for Health and Social Care, what assessment she has made of the contribution of UK research to improving outcomes for people with type 1 diabetes.

Asked by
Oliver Dowden (Conservative)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Tabled
Date
28 August 2026
Reference
21188
House
House of Commons

To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential benefits of funding immunotherapy research for people with early-stage type 1 diabetes.

Asked by
Juliet Campbell (Labour)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Tabled
Date
28 August 2026
Reference
22318
House
House of Commons

To ask the Secretary of State for Health and Social Care, what steps her department is taking to increase localised preventive care and diagnostic capacity in parliamentary constituencies where UK Health Security Agency profile data indicates Type 2 diabetes prevalence exceeds 12 per cent, such as Leicester East.

Asked by
Shivani Raja (Conservative)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Tabled
Date
28 August 2026
Reference
22345
House
House of Commons

To ask the Minister for the Cabinet Office, what estimate he has made of the annual productivity costs associated with diabetes including sickness absence, reduced economic participation and premature mortality.

Asked by
Roz Savage (Liberal Democrat)
Answering body
Cabinet Office
Type
Written questions
Status
Tabled
Date
28 August 2026
Reference
25322
House
House of Commons

To ask the Secretary of State for Health and Social Care, what steps he is taking to to ensure continuity of leadership for early-stage type 1 diabetes policy and service development during the transition of functions from NHS England to his Department.

Asked by
Oliver Dowden (Conservative)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
17 July 2026
Reference
17765
House
House of Commons

To ask the Secretary of State for Health and Social Care, what discussions he has had with NHS bodies regarding a future screening programme for early-stage type 1 diabetes.

Asked by
Oliver Dowden (Conservative)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
17 July 2026
Reference
17764
House
House of Commons

To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that the introduction of teplizumab contributes to reducing rates of diabetic ketoacidosis at diagnosis and inequalities in outcomes for people with type 1 diabetes.

Asked by
Cat Eccles (Labour)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
14 July 2026
Reference
15868
House
House of Commons

To ask the Secretary of State for Science, Innovation and Technology, what assessment she has made of the UK's position globally in respect of research into beta cell preservation, regeneration and replacement therapies for type 1 diabetes.

Asked by
John Hayes (Conservative)
Answering body
Department for Science, Innovation and Technology
Type
Written questions
Status
Answered
Date
10 July 2026
Reference
14779
House
House of Commons

To ask the Secretary of State for Health and Social Care, what data the Department holds on (a) the number and proportion of dopamine agonist-treated patients who report binge eating or marked weight gain, (b) weight and metabolic monitoring practices when dopamine agonists are started or doses increased, (c) the...

Asked by
Lee Pitcher (Labour)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
8 July 2026
Reference
9203
House
House of Commons

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help accelerate the translation of beta cell research into clinical trials and routine NHS care for people with type 1 diabetes.

Asked by
Cat Eccles (Labour)
Answering body
Department of Health and Social Care
Type
Written questions
Status
Answered
Date
8 July 2026
Reference
15867
House
House of Commons

Motion that this House has considered the matter of reducing levels of premature deaths from heart disease and stroke. Agreed to on question.

Lead member
Paul Foster
Answering member
Sharon Hodgson; Stuart Andrew
Department
Department of Health and Social Care
Type
Debates
Date
2 July 2026
Reference
788 cc504-483WH
House
House of Commons

I beg to move,

That this House has considered the matter of reducing levels of premature deaths from heart disease and stroke.

It is an honour to serve under your chairmanship, Dame Siobhain. I thank hon. Members for attending the debate.

Cardiovascular disease remains one of the United Kingdom’s biggest killers and one...

Member
Paul Foster (Labour)
Type
Proceeding contributions
Date
2 July 2026
Reference
788 cc504-462WH
House
House of Commons

My hon. Friend is making an important and passionate speech, especially in the light of the personal circumstances that he mentioned. I agree with him about deprivation. Does he agree that access to fresh, affordable food is incredibly important, particularly in the most deprived areas? In Castlemilk in my constituency,...

Member
Gordon McKee (Labour)
Type
Proceeding contributions
Date
2 July 2026
Reference
788 c462WH
House
House of Commons

I absolutely agree. If we could get fresh food to more of our communities and young people, it would have a massive positive effect on dealing with CVD—that must be dealt with.

This debate could not be more timely. The Government have rightly identified CVD as one of the UK’s biggest...

Member
Paul Foster (Labour)
Type
Proceeding contributions
Date
2 July 2026
Reference
788 cc462-3WH
House
House of Commons
Type
Proceeding contributions
Date
2 July 2026
Reference
788 c463WH
House
House of Commons